BamSEC and AlphaSense Join Forces
Learn More

Shire Plc

Formerly OTC: SHPGF
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 56 pages Dated 8 May 2018 Takeda Pharmaceutical Company Limited and Shire Plc Co-Operation Agreement Slaughter and May One Bunhill Row London Ec1y 8yy (Memh/Cvkb/Clxj) 552275533
12/34/56
EX-2.1
from 8-K 109 pages Agreement and Plan of Merger Among Shire Plc Beartracks, Inc. and Baxalta Incorporated Dated as of January 11, 2016
12/34/56
EX-2.1
from 425 109 pages Agreement and Plan of Merger Among Shire Plc Beartracks, Inc. and Baxalta Incorporated Dated as of January 11, 2016
12/34/56
EX-2.1
from 8-K 118 pages Agreement and Plan of Merger Among Dyax Corp., Shire Pharmaceuticals International, Parquet Courts, Inc. and Shire Plc Dated as of November 2, 2015
12/34/56
EX-2.1
from 8-K 81 pages Agreement and Plan of Merger Dated as of January 11, 2015 Among Nps Pharmaceuticals, Inc., Shire Pharmaceutical Holdings Ireland Limited, Knight Newco 2, Inc. and Shire Plc
12/34/56
EX-2.1
from SC TO-C 81 pages Agreement and Plan of Merger Dated as of January 11, 2015 Among Nps Pharmaceuticals, Inc., Shire Pharmaceutical Holdings Ireland Limited, Knight Newco 2, Inc. and Shire PLC
12/34/56
EX-2.1
from 8-K 18 pages 20 October 2014 Abbvie Inc. and Shire Plc Termination Agreement Herbert Smith Freehills Llp
12/34/56
EX-2.2
from 8-K 33 pages 18 July 2014 Abbvie Inc and Shire Plc Co-Operation Agreement Herbert Smith Freehills Llp
12/34/56
EX-2.1
from 8-K 43 pages Recommended Combination of Shire Plc and Abbvie Inc
12/34/56
EX-2.2
from 425 44 pages 18 July 2014 Abbvie Inc and Shire Plc Co-Operation Agreement Herbert Smith Freehills Llp 1
12/34/56
EX-2.1
from 425 43 pages Recommended Combination of Shire Plc and Abbvie Inc
12/34/56
EX-2.1
from 8-K 65 pages Asset Purchase Agreement Dated as of January 16, 2014 Among Organogenesis Inc., Shire US Holdings, Inc. and Shire Regenerative Medicine, Inc
12/34/56
EX-2.1
from SC TO-C 87 pages Agreement and Plan of Merger Dated as of November 11, 2013, Among Shire Pharmaceutical Holdings Ireland Limited, Venus Newco, Inc., Viropharma Incorporated and Shire Plc
12/34/56
EX-2.1
from 8-K 87 pages Agreement and Plan of Merger Dated as of November 11, 2013, Among Shire Pharmaceutical Holdings Ireland Limited, Venus Newco, Inc., Viropharma Incorporated and Shire Plc
12/34/56
EX-2.6
from 10-Q/A 83 pages Agreement and Plan of Merger Dated as of March 14, 2012 by and Among Shire Pharmaceuticals LLC, Pelegrina Corporation, Ferrokin Biosciences, Inc. and Shareholder Representative Services LLC, as the Equityholders’ Representative
12/34/56
EX-2.1
from 8-K 71 pages Agreement and Plan of Merger Dated as of May 17, 2011 by and Among Shire Pharmaceuticals Inc. (“Parent”), Abh Merger Sub Inc. (“Merger Sub”), Advanced Biohealing, Inc. (The “Company”), Solely for the Purposes of Section 2.7 and Articles III, IX and X, Canaan VII L.P. (The “Equityholders’ Representative”) And, Solely for the Purposes of Section 10.17, Shire Plc
12/34/56
EX-2.4
from 10-Q 10 pages Heads of Agreement Relating to a Friendly Tender Offer for Mnv
12/34/56
EX-2.1
from 8-K 26 pages Defined Terms
12/34/56
EX-2.1
from SC TO-C 118 pages Agreement of Merger Dated as of February 20, 2007 Among Shire Plc, Shuttle Corporation and New River Pharmaceuticals Inc
12/34/56
EX-2.1
from 8-K 118 pages Agreement of Merger Dated as of February 20, 2007 Among Shire Plc, Shuttle Corporation and New River Pharmaceuticals Inc
12/34/56